New drug trial offers hope for painful skin condition
NCT ID NCT07151937
Summary
This study is testing a new drug called LAD191 for adults with moderate-to-severe hidradenitis suppurativa (HS), a painful skin condition. Researchers will compare different doses of LAD191 against a placebo and an existing drug (adalimumab) to see which is better at reducing the number of painful lumps and tunnels under the skin. The main goal is to see if LAD191 can help at least half of the participants achieve a 50% reduction in their skin lesions over 16 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.